Search Results 1161-1170 of 16736 for intermittent fasting optimization

  1. General Internal Medicine - Clinical trials

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  2. Antihypertensive Treatment Of Acute Cerebral Hemorrhage (ATACH-II) - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  3. Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  4. BoxX-NoAF Clinical Trial

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  5. Medical Research & Education - Mayo Clinic News Network

    ... optimize care featured. Research. Mayo study uses electronic health record data to assess metformin failure risk, optimize care. Vincent Jacobbi. February 10 ...

  6. A Study to Assess Frailty and Its Impact on Patients with Pulmonary Hypertension - Mayo Clinic

    The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our institution.

  7. A Study of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy ...

  8. A Study of the Measurement of Blood Sugar Variation in Type 1 Diabetic Children, and Finding the Causes - Mayo Clinic

    no eating disorder; high likelihood of compliance with protocol and completion of study; absence of an intercurrent illness during the study period. Healthy ...

  9. Study Evaluating The Safety And Efficacy Of Semaglutide, And The Fixed-Dose Combination Of Cilofexor And Firsocostat, Alone And In Combination, In Participants With Compensated Cirrhosis (F4) Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later phase (phase 3) ... the Modification of Diet in Renal Disease (MDRD) equation; - HbA1c ≤ 10%; - INR ...

  10. Neurology - Clinical trials - Mayo Clinic

    Rochester, Minn. The goal of this study is to evaluate and optimize our existing phosphorus MRI head coil and imaging sequence on healthy human volunteers. A ...